Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
1.770
-0.020 (-1.12%)
At close: Oct 24, 2024, 4:00 PM
1.830
+0.060 (3.39%)
After-hours: Oct 24, 2024, 4:28 PM EDT

Accelerate Diagnostics Market Cap

Accelerate Diagnostics has a market cap or net worth of $41.91 million as of October 24, 2024. Its market cap has decreased by -53.79% in one year.

Market Cap
41.91M
Enterprise Value
74.58M
1-Year Change
-53.79%
Ranking
Category
Stock Price
$1.77

Market Cap Chart

Since December 1, 1998, Accelerate Diagnostics's market cap has increased from $21.70M to $41.91M, an increase of 93.15%. That is a compound annual growth rate of 2.57%.

History

DateMarket Cap% Change
Oct 23, 202442.40M-25.61%
Dec 29, 202357.00M-18.57%
Dec 30, 202270.00M-79.56%
Dec 31, 2021342.50M-20.77%
Dec 31, 2020432.30M-53.19%
Dec 31, 2019923.50M48.16%
Dec 31, 2018623.30M-57.06%
Dec 29, 20171.45B35.99%
Dec 30, 20161.07B11.02%
Dec 31, 2015961.40M12.30%
Dec 31, 2014856.10M69.22%
Dec 31, 2013505.90M395.49%
Dec 31, 2012102.10M661.94%
Dec 30, 201113.40M26.42%
Dec 31, 201010.60M23.26%
Dec 31, 20098.60M-63.40%
Dec 31, 200823.50M-49.13%
Dec 31, 200746.20M132.16%
Dec 29, 200619.90M-34.32%
Dec 30, 200530.30M44.98%
Dec 31, 200420.90M-1.88%
Dec 31, 200321.30M56.62%
Dec 31, 200213.60M-16.05%
Dec 31, 200116.20M575.00%
Dec 29, 20002.40M-76.47%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Immix Biopharma 45.29M
Aligos Therapeutics 45.25M
Rallybio 44.81M
CollPlant Biotechnologies 44.67M
DURECT 44.08M
Lexaria Bioscience 43.64M
Daxor 43.56M
CalciMedica 43.32M
Market Cap Rankings